title: [Effect of phytotherapy on the prevention and elimination of hepatotoxic responses in patients with pulmonary tuberculosis, carriers of hepatitis B virus markers].
abstract: Whether hepatotoxic responses (HTR) can be prevented and corrected in patients with pulmonary tuberculosis, carriers of hepatitis B virus markers during specific therapy by using preventive hepatoprotective phytotherapy was studied. Group 1 (n = 54) was given individually chosen plant species infusions having a pronounced heptoprotective effect (liquorice (Glycyrrhiza L.), nettle (Urita L.), tansy (Tanacotum L.), mint (Mentha L.), etc.)) in the whole course of antituberculous treatment. A control group (n = 58) received essentiale, legilon, Liv-52, hemodez from the onset of HTR to their elimination. Phytotherapy was found to reduce to occurrence of HTR by 4.1 times, to eliminate them 2.1 times more rapidly, to shorten the periods of discontinuation of antituberculous agents by 2.1 times, which positively affects the time and efficiency of treatment for tuberculosis.
authors.affiliation: Military Medical Academy, Saint-Petersburg.
authors.forename: L A
authors.initials: LA
authors.lastname: Galitskií
authors.forename: O D
authors.initials: OD
authors.lastname: Barnaulov
authors.forename: B V
authors.initials: BV
authors.lastname: Zaretskií
authors.forename: M I
authors.initials: MI
authors.lastname: Malkov
authors.forename: S I
authors.initials: SI
authors.lastname: Konenkov
authors.forename: N P
authors.initials: NP
authors.lastname: Gol'm
authors.forename: V S
authors.initials: VS
authors.lastname: Tomakov
authors.forename: P I
authors.initials: PI
authors.lastname: Ogarkov
authors.forename: S S
authors.initials: SS
authors.lastname: Batskov
mesh_terms: D000328:Adult; D000995:Antitubercular Agents / Q000009:adverse effects*; D015415:Biomarkers / Q000097:blood; D005260:Female; D006509:Hepatitis B / Q000150:complications / Q000276:immunology*; D006510:Hepatitis B Antibodies / Q000097:blood*; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D008099:Liver / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D008517:Phytotherapy; D014397:Tuberculosis, Pulmonary / Q000150:complications / Q000276:immunology / Q000628:therapy*
chemical_list: D000995:Antitubercular Agents; D015415:Biomarkers; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens